Aminoglycoside ototoxicity. An update, with implications for all drug therapies.

scientific article published in April 1985

Aminoglycoside ototoxicity. An update, with implications for all drug therapies. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/00325481.1985.11698953
P698PubMed publication ID3872449

P2093author name stringJohnson JT
Kamerer DB
P2860cites workDouble-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycinQ34056699
Aminoglycoside ototoxicity in the humanQ34057509
The effect of kanamycin on the cation content of the endolymphQ48789372
Some observations on dosage and toxicity of kanamycin in premature and full-term infantsQ50253398
Comparative ototoxicity of amikacin, gentamicin, netilmicin, and tobramycin in guinea pigs.Q50595467
Ototoxicity of Gentamicin in Man: A Survey and Controlled Analysis of Clinical Experience in the United StatesQ50645402
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectototoxicityQ1351381
P304page(s)131-4, 138
P577publication date1985-04-01
P1433published inPostgraduate MedicineQ7234297
P1476titleAminoglycoside ototoxicity. An update, with implications for all drug therapies.
P478volume77

Reverse relations

cites work (P2860)
Q48309663Aminoglycoside ototoxicity in pediatric patients receiving long-term peritoneal dialysis
Q38676819Aminoglycoside-induced hearing loss in humans